USPTO 2015–2025 USPTO PatentsView US Corporation

Thrive Bioscience, Inc.

USPTO PatentsView assignee record - 30 granted patents across 13 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme).

RSS updates for this company

The verdict

According to USPTO PatentsView, Thrive ranks #10,480 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 13 technology areas.

#10,480
of 49,997 US assignees by volume
Top 7%
by Innovation Score (55.8/100)
18.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R10480 · US Corporation #10,480 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 30 grants
  • UPPER-Q #10,480/49,997
  • PHOTO-FINISH Technology Innovatio…
  • CPC-FOCUS C12M · 13 areas
  • INNOV-PAR 55.8/100
  • CLAIMS-RICH 18.6 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Technology Innovation Momentum Fund (Israel) Limited Partnership (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Thrive’s 55.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Thrive

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Thrive's Innovation Score is 55.8/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Thrive?

Each dot is one of Thrive’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Thrive’s own 18.6 claims/patent is ABOVE the 13.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Thrive vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 29.93030.1 510152025 Granted patents (volume) Avg claims / patent Technology Innovation Momentum Fund (Israel) Limited Partnership - 30, 18.9Technology Innova…Tensorcom, Inc. - 30, 18.4TensorcomThe Technology Partnership PLC - 30, 18.8The Technology Pa…The University of Memphis Research Foundation - 30, 13.87The University of…Thule NV - 30, 8.37ThuleTokyo Parts Industrial Co., Ltd. - 30, 9.53Tokyo Parts Indus…Topgolf International, Inc. - 30, 11.87Topgolf Internati…Travel Caddy, Inc. - 30, 20.17Travel CaddyThrive Bioscience, Inc. - 30, 18.57Thrive Bioscience
Thrive vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Thrive's grants concentrate

Thrive Bioscience, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 93.3% of grants classified under C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme). Peak complete grant year is 2024 (10 grants) versus a trough of 1 in 2020. By volume, Thrive sits between Technology Innovation Momentum Fund (Israel) Limited Partnership and Travel Caddy, Inc..

Thrive's three-year grant acceleration

Thrive Bioscience, Inc. shows 21 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Thrive's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Thrive holds 30 patents at rank #10,486, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Thrive

By rank, the assignees closest to #10,486 in granted patent volume.

Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)

Other assignees with the most granted patents in Thrive's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Thrive, neither rank-band nor same-CPC leaders (those blocks stay above). In C12M (Apparatus FOR Enzymology OR Microbiology), Thrive ranks #22 of 832 assignees by patent count in that subclass.

Thrive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 202020212022202320242025 4
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Thrive Bioscience, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 3.3%
2021 4 13.3%
2022 4 13.3%
2023 7 23.3%
2024 10 33.3%
2025partial year 4 13.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Thrive Bioscience, Inc.'s patent record in context - here's where to go next.

  • Thrive Bioscience, Inc.'s lead technology class is C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme), 93.3% of its portfolio - see every assignee active in that class. Explore C12M
  • Ranked #10,480 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Thrive Bioscience, Inc. against Technology Innovation Momentum Fund (Israel) Limited Partnership, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 55.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.